We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Varian Acquires IonSpec

By Biotechdaily staff writers
Posted on 10 Mar 2006
Varian, Inc. (Palo Alto, CA, USA) has acquired IonSpec Corp. (Lake Forest, CA, USA) for approximately U.S.$16 million.

Varian said the acquisitions of IonSpec's Fourier transform mass spectrometry (FTMS) technology represents a significant step toward expanding its information-rich detection (IRD) portfolio.

Varian expects the acquisition to increase its development of growing life science applications, specifically the study of proteins, nucleic acids, and drug metabolites. The initial cash purchase price includes paying down assumed debt and an opportunity for an additional payment if FTMS products reach specified financial targets over a three-year period.

FTMS instruments are used in laboratories worldwide to determine the function and structural characterization of proteins and other biomolecules in various biologic systems.




Related Links:
Varian
IonSpec

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
10 Mar 2006  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
10 Mar 2006  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
10 Mar 2006  |   BioResearch